Table 2.
Factors | n | IRR (95 % CI) | p-Value a |
---|---|---|---|
Age | |||
⩽60 | 24 | 1.225 (1.136–1.321) | <0.01* |
>60 | 21 | Ref | |
Gender | |||
Male | 25 | 1.044 (0.968–1.125) | 0.262 |
Female | 20 | Ref | |
ASA | |||
1 | 30 | Ref | |
2 | 12 | 0.76 (0.69–0.83) | <0.01* |
3 | 3 | 0.81 (0.70–0.95) | <0.01* |
NRS/Q-SGA | |||
A | 24 | Ref | |
B | 17 | 0.91 (0.84–0.99) | 0.023* |
C | 4 | 0.81 (0.70–0.93) | 0.004* |
Tumor location | |||
Cecum | 7 | Ref | |
Ascending | 6 | 0.94 (0.83–1.07) | 0.366 |
Hepatic flexure | 8 | 0.82 (0.72–0.92) | 0.001* |
Transverse | 2 | 0.68 (0.55–0.84) | <0.001* |
Splenic flexure | 2 | 0.55 (0.44–0.69) | <0.001* |
Descending | 3 | 0.91 (0.78–1.06) | 0.230 |
Sigmoid | 17 | 0.66 (0.59–0.73) | <0.001* |
CEA level | |||
Non elevated ⩽5 ng/ml | 26 | Ref | |
Evaluated | 19 | 1.07 (0.99–1.15) | 0.088 |
pT | |||
1 | 2 | 0.57 (0.44–0.73) | <0.001* |
2 | 21 | 0.95 (0.83–1.08) | 0.398 |
3 | 18 | 0.82 (0.72–0.93) | 0.003* |
4 | 4 | Ref | |
pN | |||
No | 28 | 1.13 (1.04–1.22) | 0.003* |
N1–3 | 17 | Ref | |
AJCC 8th stage | |||
I | 20 | 1 | |
II | 8 | 0.88 (0.79–0.98) | 0.016* |
III | 17 | 0.86 (0.79–0.93) | <0.01* |
Histology | |||
High | 34 | Ref | |
Moderate | 9 | 0.82 (0.74–0.90) | <0.01* |
Low | 2 | 0.92 (0.77–1.11) | 0.383 |
Tumor size | |||
⩽4.5 | 26 | Ref | |
>4.5 | 19 | 1.22 (1.14–1.32) | <0.01* |
Specimen length | |||
⩽25 | 17 | Ref | |
>25 | 28 | 1.14 (1.05–1.23) | 0.001* |
Negative binomial with log link.
p < 0.05.